About Prometheus Laboratories
Prometheus Laboratories is a company based in San Diego (United States) founded in 1995 was acquired by Nestlé Health Science in May 2011. The company has 474 employees. Prometheus Laboratories offers products and services including Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus. Prometheus Laboratories operates in a competitive market with competitors including Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals, Given Imaging and EnteraSense, among others.
- Headquarter San Diego, United States
- Employees 474
- SectorsHealthcare
- Website prometheuslabs.com
- Social LinkedIn Facebook
- Acquired by Nestlé Health Science (May 2011)
- Legal Name Prometheus Laboratories Inc
- Latest Funding Round$260M (USD), Debt – Conventional
Jan 2010
- InvestorsNestlé Health Science
& 2 more
- Employee Count474
- Acquired byNestlé Health Science
(May 2011)
Products & Services of Prometheus Laboratories
Prometheus Laboratories offers a comprehensive portfolio of products and services, including Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus.
Monitors infliximab levels for effective IBD treatment management.
Assesses adalimumab levels in patients with gastrointestinal conditions.
Evaluates disease activity for inflammatory bowel disease monitoring.
Detects celiac disease through genetic and serological analysis.
Funding Insights of Prometheus Laboratories
- Total Rounds 3
- Last Round Debt – Conventional — $260M
- Investors Count 2
All 3 funding rounds of Prometheus Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2010 | $260M | Debt – Conventional | – | – | – |
| Nov 2009 | $136,500 | Grant | – | – | |
| Jun 1999 | – | Series B | – | – |
3 investors in total: 3 institutional.
Investors in Prometheus Laboratories
Prometheus Laboratories has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Nestlé Health Science, Pamlico Capital and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pamlico Capital is engaged in private equity investments for growth companies. | – | pamlicocapital.com | Charlotte, United States | |
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Nutritional dietary supplements are provided for health and wellness needs. | 2011 | nestlehealthscience.com | Epalinges, Switzerland |
Investor details for Prometheus Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Prometheus Laboratories
62 people are tracked at Prometheus Laboratories (20 in leadership, 6 in board & advisors, 36 in team); the tracked headcount is 474.
| Name | Role | Group |
|---|---|---|
Joseph Limber | CEO | Leadership |
Tammy Taylor | Director, Human Resources | Leadership |
Thierry Dervieux | Chief Scientific Officer | Leadership |
Dennis Takasugi | Head, Commercial Development & Planning | Leadership |
Don Murphy | Director, Oncology Marketing | Leadership |
Judith Gohndrone | Marketing Director | Leadership |
Kwaku L.C. Woods | Chief Operations Officer | Leadership |
Melinda Diamond | Sr. Director, Human Resources | Leadership |
Bita Sabet | A Director Of IT Project Coordinator And Software Quality Engineer | Leadership |
Subra Mallampalli | Director, Information Technology | Leadership |
Kendal Jensen | Laboratory Director | Leadership |
Patricia Hughes | Senior Director, Clinical Laboratory | Leadership |
Nikki Malie | Director, Market Access & Value | Leadership |
Norma Kreischer | Associate Director, Quality Systems Engineering | Leadership |
Dani Fletes | Director, Prometheus Labs | Leadership |
Rachel Ako | Sr. Regional Technical Specialist For The Pacific Region (ca & Hi), President’s Club Award Winner | Leadership |
Lewis Rutledge | Associate Director, Client Operations | Leadership |
Juan Estruch | Head, Business Development | Leadership |
Jessica Ho | Associate Director | Leadership |
Samik Banerjee | Director Commercial Operations | Leadership |
42 more people are available in the full profile.
Complete people profiles for Prometheus Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Prometheus Laboratories
4 dated milestones of Prometheus Laboratories across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Prometheus Laboratories is founded.
- Funding First funding round.
- Funding Latest funding round, Debt – Conventional, of $260.0M.
- Exit Acquired by Nestlé Health Science.
Competitors of Prometheus Laboratories
Prometheus Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals, Given Imaging and EnteraSense, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viomelifesciences.com | 2016 | Bothell, United States | $92.44M | 136 | Provider of tests to prevent, treat, and cure chronic diseases, and cancer | |
| ninepointmedical.com | 2008 | Bedford, United States | $98.26M | 25 | Optical coherence tomography systems for tissue microstructure imaging are developed. | |
| indexpharma.com | 2000 | Stockholm, Sweden | $45.42M | – | DNA-based immunomodulatory drugs for ulcerative colitis are developed. | |
| givenimaging.com | 1998 | Minneapolis, United States | – | – | Capsule endoscopy systems for GI imaging | |
| enterasense.com | 2016 | Galway, Ireland | $1.14M | – | Ingestible biosensor for GI disease | |
| gtechmedical.com | 2010 | Mountain View, United States | $6.93M | 3 | Diagnostic device company | |
| xillix.com | 2002 | Toronto, Canada | $5.5M | – | Develops real-time fluorescence imaging systems for medical applications. | |
| goodgut.eu | 2014 | Girona, Spain | $900,240 | – | Diagnosis and treatment of digestive diseases based on intestinal microbiota analysis | |
| stelladx.com | 2020 | New York, United States | – | – | Molecular diagnostics solutions for esophageal diseases are developed. |
Detailed competitors of Prometheus Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Prometheus Laboratories
The website of Prometheus Laboratories (prometheuslabs.com) receives about 5K visits a month.
- Monthly visits5K
▼ 9.7% vs previous month
Websites whose visitors overlap most with Prometheus Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
sdrl.com | sdrl.com | 100% | – | – | – |
| ndssi.com | 74% | 3.5K | #5,118,353 | View details | |
| pharmatek.com | 73% | – | – | View details | |
| salix.com | 64% | 15.6K | #1,433,848 | View details | |
| pacificedgedx.com | 52% | 3.2K | #9,214,813 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Prometheus Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Prometheus Laboratories
Complete news archive for Prometheus Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Prometheus Laboratories
10 companies that operate in the same segment as Prometheus Laboratories (Gastroenterology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Implantable battery-powered pumps for ascites removal are developed. | 2006 | Zurich, Switzerland | USD 35.5 M | – | – | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | – | 533 | |
Developer of electrosurgical system and range of flexible endoscopic instruments | 2003 | Chepstow, Monmouthshire, United Kingdom | USD 20.84 M | USD 8.08 M | 141 | |
Non-invasive biomarker tests for colorectal cancer are developed. | 2015 | St. Louis, Missouri, United States | USD 218.95 M | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | 2009 | Ramat Gan, Tel Aviv District, Israel | USD 13.5 M | USD 288.27 K | 35 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Prometheus Laboratories
Prometheus Laboratories was founded in 1995 and raised its 1st funding round 4 years after it was founded.
Prometheus Laboratories is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Joseph Limber is the current CEO of Prometheus Laboratories.
Prometheus Laboratories has 474 employees.
Prometheus Laboratories develops diagnostics for the gastrointestinal space. As of Jan 2016, it offers diagnostics for patient responsiveness to infliximab and adalimumab, irritable bowel syndrome, celiac disease, thipurine metabolite and liver fibrosis in Hep C patients, and prognostics for Crohns disease. In addition, the company also provides genetic tests for lactose intolerance and a therapeutic product proleukin for metastatic melanoma and kidney cancer. In May 2011, Prometheus became a subsidiary of Nestlé Health Science.
Prometheus Laboratories's top competitors include Viome Life Sciences, NinePoint Medical and InDex Pharmaceuticals.
Prometheus Laboratories offers Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus.
Prometheus Laboratories has 3 investors. Key investors include Nestlé Health Science, Pamlico Capital, and National Science Foundation.
Prometheus Laboratories operates through Prometheus Laboratories Inc.
Yes. Prometheus Laboratories was acquired by Nestlé Health Science in May 2011.